Novel breakthroughs in advanced prostate cancer management-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Novel breakthroughs in advanced prostate cancer management

Published:2023-03-28 Issue:4 Volume:23 Page:369-373
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Lilly Eddy¹^ORCID,Sarkis Julien¹^ORCID,Mahmoud Omar²,El Gharib Khalil³^ORCID,Sarkis Pierre⁴,Nemr Elie¹

Affiliation:

1. Urology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon

2. Hematology-Oncology Department, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon

3. Department of Medicine, STATEN Island University Hospital, New York, NY, USA

4. Department of Urology, Saint Joseph Hospital, Beirut, Lebanon

Funder

This paper received no funding

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737140.2023.2195166

Reference18 articles.

1. Clinical implications of PTEN loss in prostate cancer

2. Olaparib for Metastatic Castration-Resistant Prostate Cancer

3. Clinical implications of mismatch repair deficiency in prostate cancer

4. Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP